Toby C. Trujillo, PharmD, BCPS (AQ Cardiology)

Work Contact Information: Associate Professor, Department of Clinical Pharmacy University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Anschutz Medical Campus Clinical Specialist - Anticoagulation/Cardiology University of Colorado Hospital C238-V20 Pharmacy & Pharmaceutical Sciences 12850 E. Montview Blvd. Room V20-1217 Aurora, CO 80045 Office: 303-724-2623 Email: Toby.Trujillo@ucdenver.edu

Home Contact Information: 1904 Breen Lane Superior, CO 80027 Home: 720-381-0052 Mobile: 617-510-5842 Email: tobytrujillo12@gmail.com EDUCATION 1990-1994 Doctor of Pharmacy

University of California-San Francisco School of Pharmacy San Francisco, California

1985-1990 B.S. Biochemistry

University of California-Davis Davis, California

PHARMACY LICENSURE/CERTIFICATION Colorado (#18277) California (#47586) Board Certified Pharmacotherapy Specialist with Added Qualifications in Cardiology (ID #299247)

PROFESSIONAL EXPERIENCE Post Doctor of Pharmacy Training 1995-1997 Fellowship in Cardiovascular Pharmacotherapy

University of Arizona College of Pharmacy/University Medical Center Department of Pharmacy Practice/Department of Pharmacy Services Tucson, Arizona Preceptor: Paul E. Nolan, Jr., Pharm.D., FASHP, FCCP

1994-1995 Residency in Pharmacy Practice

University of California-San Francisco School of Pharmacy San Francisco, California

Academic Appointments 2008-Present Associate Professor. University of Colorado Skaggs School of Pharmacy and

Pharmaceutical Sciences. Aurora, CO. 2005-2008 Clinical Associate Professor in Pharmacy Practice. Northeastern University School

of Pharmacy, Boston, Massachusetts. 2004-2005 Clinical Assistant Professor in Pharmacy Practice.

Northeastern University School of Pharmacy, Boston, Massachusetts. 2002-2004 Adjunct Assistant Professor of Clinical Pharmacy.

Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts 1997-2001 Assistant Professor of Clinical Pharmacy.

Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts. Pharmacy Experience 2009-Present Clinical Specialist in Cardiovascular Pharmacotherapy / Anticoagulation and

Director, Inpatient Anticoagulation – Thrombosis Management Service. University of Colorado Hospital, Aurora, CO

2008-2009 Clinical Coordinator. University of Colorado Hospital, Anschutz Medical Campus.

Aurora, CO. 2003-2008 Program Director, PGY2 Cardiology Specialty Residency.

Boston Medical Center, Boston, Massachusetts. ASHP accredited. 2002-2006 Program Director, PGY1 Pharmacy Practice Residency Program.

Boston Medical Center, Boston, Massachusetts. ASHP accredited. 2002-2008 Clinical Coordinator

Clinical Specialist – Cardiology/Anticoagulation Boston Medical Center, Boston, Massachusetts.

1998-2001 Program Director, Pharmacy Practice Residency Program. Beth Israel Deaconess Medical Center in association with The Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts. ASHP accredited.

1997-2001 Cardiovascular Pharmacotherapy Specialist.

Beth Israel Deaconess Medical Center, Boston, Massachusetts. 1995-1997 Cardiovascular Pharmacotherapy Specialist.

University Medical Center, Tucson, Arizona 1994-1995 Clinical Pharmacist

University of California-San Francisco Medical Center, San Francisco, California. TEACHING EXPERIENCE University of Colorado – Denver School of Pharmacy

Colorado Residency Teaching Certificate Program 2010-present Developed, coordinated and implemented a city-wide (Denver, CO)

residency teaching certificate program. Course Coordination

2010-present PHRD 6250: Course Coordinator for Instructional Methods II, P2 year. 2009-present PHRD 6100: Course Coordinator for P2 skills

Doctor of Pharmacy Program Teaching 2009-present PHRD 7650: Comprehensive Patient Care. Developed and delivered

active learning module on ACS, ADHF, HIT and chronic stable angina. Served as group facilitator.

2008-present PHRD 6720: Integrated Organ Systems 5. Lectured on the patholysiology of thrombosis, optimization of anti-thrombotic therapy, prevention and treatment of VTE, and treatment of atrial fibrillation

2008 PHRD 6700: Integrated Organ Systems 3 and 4. Lectured on chronic stable angina.

2008 PHRD 4100: P2 Skills. Case discussion on anticoagulation

Experiential Teaching 2011-present PHRD 8700: Rotation preceptor for P4 APPE students in cardiology and

anticoagulation 2009-present PHRD 6300: Served as a mentor for hospital IPPE experience for P2 and

P3 students 2008-2009 PHRD 7300: IPPE hospital experience coordinator for P2 and P3 students

Northeastern University School of Pharmacy

Doctor of Pharmacy Program Teaching 2006-2007 PMD G243: Therapeutics Seminar 2. Served as group facilitator for small

group discussions 2006-2007 PMD U401: Pathophysiology. Lectured on hemostasis/thrombosis, ischemic heart

disease, and heart failure 2003-2007 PMD 542: Therapeutics. Lectured on ischemic heart disease, acute coronary

syndromes, heart failure, and arrhythmias

Experiential Teaching 2003-2007 PMD 1605: Clinical Clerkship in anticoagulation for Doctor of Pharmacy students.

Northeastern University School of Pharmacy 2003-2007 PMD 1605: Clinical Clerkship in cardiology for Doctor of Pharmacy students.

Northeastern University School of Pharmacy Massachusetts College of Pharmacy and Health Sciences

Course Coordination

2001 PHA 560 and 561: Course coordinator for Advanced Therapeutics. In conjunction with three other coordinators I am responsible for overall coordination of class including teaching philosophy, course content and methods of assessment. Work includes working with individual module coordinators and seminar leaders.

2001 PHA 663A and S: Pharmacotherapy Module III, Cardiopulmonary. Coordinator of cardiovascular/pulmonary module in the Doctor of Pharmacy, non-traditional pathway. Lectured on ischemic heart disease, arrhythmia's, and seminar leader for Doctor of Pharmacy, non-traditional pathway. Duties also included the development and writing of a weekly case for seminar, midterm, and final examination questions.

1999-2001 PHA 561: Advanced Therapeutics. Module coordinator for cardiology block (12 hours of lecture). Duties also include writing and grading exams and coordinating problem-based learning discussion seminar.

Doctor of Pharmacy Program Teaching

2003 PHA 667: Non-traditional Pharm.D. Program, Neurology/Psychiatry module. Massachusetts College of Pharmacy and Health Sciences. Lectured on stroke.

2002-2004 PHA 561: Advanced Therapeutics. Lectured on ischemic heart disease, acute coronary syndromes and arrhythmias.

2000-2001 PHA 562A and B: Advanced Therapeutics Seminar I and II. Served as a group facilitator on a weekly basis and evaluated students on assessment and presentation skills.

1998-2001 PHA 561: Advanced Therapeutics II. Lectured on ischemic heart disease, acute coronary syndromes, arrhythmias, congestive heart failure, cardiac transplantation, thromboembolic disease, shock/hemodynamic monitoring, and stroke. Seminar leader for Doctor of Pharmacy students. Duties also included the development and writing of weekly case and midterm examination questions.

1998-1999 PHA 481: Therapeutics II and Therapeutics II Trailer Course. Lectured on arrhythmia's and thromboembolic disease for Bachelor of Science pharmacy students. Duties also included the development and writing of midterm examination questions.

1998 PHA 663A and B: Pharmacotherapy Module III, cardiopulmonary. Coordinator of cardiovascular/pulmonary module in the Doctor of Pharmacy, non-traditional pathway. Lectured on ischemic heart disease, acute coronary syndromes, congestive heart failure, arrhythmia's, thromboembolic disease, cardiac transplantation, and seminar leader for Doctor of Pharmacy, non-traditional pathway. Duties also included the development and writing of a weekly case for seminar, midterm, and final examination questions.

1998 PHA 663C: Pharmacotherapy Module III, cardiopulmonary. Coordinator of Cardiovascular/pulmonary module in the Doctor of Pharmacy, non-traditional pathway Springfield campus, section (C). Lectured on ischemic heart disease, acute coronary syndromes, congestive heart failure, arrhythmias, thromboembolic disease, cardiac transplantation, and seminar leader for Doctor of Pharmacy, non-traditional pathway Springfield campus section (C). Duties also included the development and writing of a weekly case for seminar, midterm, and final examination questions.

1997 PHA 576: Therapeutics. Lectured on congestive heart failure for Bachelor of Science pharmacy students. Duties also included the development and writing of midterm examination questions.

Experiential Teaching

2003-2004 PHA 601-: Clinical Clerkship in anticoagulation for Doctor of Pharmacy students.

Massachusetts College of Pharmacy and Health Sciences 1998-2004 PHA 601-: Clinical Clerkship in cardiology for Doctor of Pharmacy students.

Massachusetts College of Pharmacy and Health Sciences 1998-2001 PHA 580: Practice in Pharmacy. Clinical Clerkship preceptor for Bachelor of

Pharmacy Students.

Allied Health Professional Teaching 2002 PAS 576: Clinical Therapeutics for Physician Assistant Program. Lectured on acute

coronary syndromes and arrhythmias. 1999-2001 PAS 576: Clinical Therapeutics for Physician Assistant Program. Module

coordinator for cardiology block and delivered lectures on congestive heart failure, thromboembolic disease, and arrhythmias.

ADMINISTRATIVE ACTIVITY/SERVICE University of Colorado - Denver School of Pharmacy 2010-present Chair, Student Experiential Training Committee. University of Colorado Denver –

School of Pharmacy, Aurora, CO. 2008-present Member, Student Experiential Training Committee. University of Colorado Denver

– School of Pharmacy, Aurora, CO. 2008-present Member and Chair, Residency Oversight Committee. University of Colorado

Denver – School of Pharmacy, Aurora, CO.

University of Colorado Hospital 2008- Member, Pharmacy and Therapeutics Committee. University of Colorado Hospital,

Aurora, CO. 2008- Member, MUE/ADR Committee. University of Colorado Hospital, Aurora, CO. 2008-2011 Member and Founder, Clinical Practice Committee. University of Colorado

Hospital, Aurora, CO. 2008- Member and co-chair, Anticoagulation Subcommittee. University of Colorado

Hospital, Aurora, CO. 2008- Member, CICP Formulary Subcommittee. University of Colorado Hospital, Aurora,

CO. 2008- 2009 Member, Medication Safety Committee. University of Colorado Hospital, Aurora,

CO. 2008- Member, Residency Advisory Committee. University of Colorado Hospital, Aurora,

CO. 2008- Member, Critical Care QI Committee. University of Colorado Hospital, Aurora,

CO. Boston Medical Center 2007- 2008 Member and founder, Antithrombotic Task Force. Boston Medical Center, Boston,

MA. 2006-2008 Member, Endocrine Subcommittee. Boston Medical Center, Boston, Massachusetts 2002-2008 Member. Pharmacy and Therapeutics Committee. Boston Medical Center, Boston,

Massachusetts. 2002-2008 Member. Critical Care Committee. Boston Medical Center, Boston, Massachusetts. 2002-2008 Member. Code Committee. Boston Medical Center, Boston, Massachusetts. Northeastern University School of Pharmacy 2006-2007 Member, Merit Review Committee. Department of Pharmacy Practice,

Northeastern University School of Pharmacy. Boston, MA Massachusetts College of Pharmacy and Health Sciences 2001 Member, Blackboard Advisory Committee. School of Pharmacy, Massachusetts

College of Pharmacy and Health Sciences, Boston, Massachusetts 2000-2001 Member, Taskforce on Workload. Department of Pharmacy Practice, School Of

Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts.

2000-2001 Member, Curriculum Committee. School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts.

1999-2000 Member, Search Committee: Department Chair Recruitment. Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts

1999-2000 Member, Student Conduct Board. School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts.

1999-2000 Alternate, Curriculum Committee. School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts.

1998-1999 Member. Admissions and Counseling Committee. Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts.

1998 Member, Panel of Judges, ASHP Clinical Skills Competition. Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts.

1998 Member, Search Committee: New Faculty Recruitment. Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts.

Beth Israel Deaconess Medical Center 1999 Member, CHF Committee. Beth Israel Deaconess Medical Center, Boston,

Massachusetts. 1997-2001 Member. Pharmacy Research Council. Beth Israel Deaconess Medical Center,

Boston, Massachusetts. 1997-2001 Member. Pharmacy and Therapeutics Committee. Beth Israel Deaconess Medical

Center, Boston, Massachusetts. 1997-2001 Member. Anticoagulation subcommittee (Pharmacy & Therapeutics Committee).

Beth Israel Deaconess Medical Center, Boston, Massachusetts. 1997-2001 Member. Cardiology subcommittee (Pharmacy & Therapeutics Committee). Beth

Israel Deaconess Medical Center, Boston, Massachusetts. EXTRAMURAL ADMINISTRATIVE ACTIVITY/SERVICE Professional Memberships

• American College of Clinical Pharmacy Practice and Research Network Memberships

- Adult Medicine, Ambulatory Care, Clinical Administration, Cardiology, Critical Care, Education and Training

• American Association of Colleges of Pharmacy • American Society of Health-system Pharmacists Member, Section of Clinical Specialists • American Heart Association • American College of Cardiology • International Society of Thrombosis and Hemostasis • Society of Critical Care Medicine • Heart Failure Society of America • Colorado Pharmacists Society

Professional Society Appointments and Service Activities 2011- Member – CCA Cardiosmart Advisory Board. American College of Cardiology 2011 – 2012 Member - Educational Affairs Committee. American College of Clinical Pharmacy 2010-2011 Co-chair- Summer Conference 2011 Cardiology. Society of Critical Care Medicine. 2009 – present Member – Clinical Pharmacology Committee. Subcommittee of the Council on

Clinical Cardiology, American Heart Association. 2009 – 2010 Member - Task Force on Residencies. American College of Clinical Pharmacy 2008 Member, Task Force on Health Care Costs. American College of Clinical Pharmacy 2007 – Practitioner Surveyor for PGY1 and PGY2 Cardiology Residency Programs. On

behalf of the Commission on Credentialing, American Society of Health-System Pharmacists.

2007-2008 Chair, Cardiology Practice and Research Network. American College of Clinical Pharmacy.

2007 Writing Group for PGY2 Residencies in Cardiology. Worked with ASHP accreditation services on the development of goals and objectives for PGY2 cardiology residency training programs for the purposes of accreditation for those programs. June 2007

2006-2007 Chair-elect, Cardiology Practice and Research Network. American College of Clinical Pharmacy.

2006-2007 Member, 2007 Eastern States Residency Conference Planning Committee. 2006-2008 Liaison from cardiology practice and research network (prn) for Student network

(StuNet). American College of Clinical Pharmacy. 2005-2007 Member, 2007 Annual Meeting Program Committee. American College of Clinical

Pharmacy. 2003 – 2005 Member, Clinical Practice Affairs Committee. American College of Clinical

Pharmacy. 2002-2003 Member, Committee/Task Force on Educational Affairs. American College of

Clinical Pharmacy. 2000-2002 Member, Teaching and Practice Expectations of Clinician Faculty Members Task

Force. Section of Teachers of Pharmacy Practice, American Association of Colleges of Pharmacy.

2000-2002 Member, Coordinating Committee for Pharmacy Grand Rounds. Pharmacy Grand Rounds is a monthly CE series supported by the Boston Council of Teaching Hospitals.

1998-2000 Network Facilitator for Cardiology, ASHP Section of Clinical Specialists. Duties include planning and organizing networking activities for ASHP meetings; serving as a resource to ASHP and the Section on matters relating to cardiology; facilitating exchange of information through the Specialists' Spectrum and through Specialty network Conferences in the Communication Center of the ASHP World Wide Web site.

Editorial Service/Journal Referee 2010 Drug-Induced Disease. Prevention, Detection and Management. 2nd edition

Reviewed Thromboembolic Disorders Chapter.. Bethesda: American Society of Health-System Pharmacists. 2010

2009- Currents in Pharmacy Teaching and Learning 2008 Pharmacists Guide to Lipid Management. American College of Clinical Pharmacy.

Lenexa, KS. 2000 ASHP’s PharmPrep. Case-based Board Review for the NABPLEX Exam. American

Society of Health System Pharmacists, Bethesda, MD. 2001 2000 ASHP Therapeutic Position Statement on HMG-CoA Reductase Inhibitors in the

Prevention of Atherosclerotic Disease 2000 ASHP Therapeutic Position Statement on Optimizing the Treatment of

Hypertension. 1996-PRESENT Annals of Pharmacotherapy

Pharmacotherapy Clinical Drug Investigation

AWARDS AND SCHOLARSHIPS 2000 Team award in the category of 'Innovation'. Anticoagulation Management Service.

Beth Israel Deaconess Medical Center, Boston, MA. 1999 Scholarly Publication Award, Massachusetts College of Pharmacy and Health

Sciences, Boston, MA. CLINICAL SERVICE ACTIVITES/PROGRAM DEVELOPMENT 2009-present Anticoagulation – Thrombosis Management Service: developed and implemented an

inpatient pharmacy managed anticoagulation management service. 2005-2007 Inpatient Anticoagulation Service/Antithrombotic Task Force: Designed and implemented

a pharmacist hospital-wide program for monitoring and adjusting anticoagulation regimen’s, to promote adherence to institution guidelines, improve healthcare utilization, and improve patient outcomes.

- DTI per pharmacy protocol - Enoxaparin per pharmacy protocol 2004 ICU Sedation Pharmacist Rounds: In conjunction with critical care specialists, designed and

implemented a pharmacist hospital-wide program for monitoring and adjusting sedation practices in the ICU’s to promote adherence to institution guidelines, improve healthcare utilization, and improve patient outcomes.

2004 Pharmacy Discharge Counseling Service: In conjunction with internal medicine and

ambulatory specialists, physicians, and nurses developed a process to target appropriate patients to receive counseling on medications prior to discharge and also receive follow-up post-discharge.

2004 Multidisciplinary Heart Failure Monitoring Service: In conjunction with cardiomyopathy

physicians and nurses, developed a multidisciplinary process whereby acute decompensated heart failure is monitored and improved in patients admitted to Boston Medical Center.

2004 Antibiotic Management Team: Coordinated development of multidisciplinary team to

proactively monitor antibiotic use within Boston Medical Center. Members of team include ID pharmacy specialist, pharmacy residents, clinical pharmacists and an ID physician.

2003 Pharmacy Nutrition Support Service: Coordinated the development and establishment of

pharmacy services within the multi-disciplinary nutrition support service for Boston Medical Center.

2002 Decentralized Pharmacist Program: Developed and implemented training program designed

to prepare staff pharmacists from a central distributive to a decentralized model of practice. 2000 Heparin Dosing Protocol: Developed and implemented an hospital wide heparin

dosing protocol including orders and in-servicing appropriate healthcare personnel. Beth Israel Deaconess Medical Center, Boston, MA.

GRANT/RESEARCH ACTIVITY Funded Grants

1. Title: VTE Clinical Care Pathway to Improve Efficiency and Outcomes Funding Agency: University of Colorado Hospital Patient safety Grant Role: Co-investigator Percent Effort: 5% Salary Offset: None Direct Costs: $14,000 Score: N/A Funded: Yes Funding Period: September 2010 -2012

2. Title: Evaluation of Care Alert Systems for medication Safety

Funding Agency: University of Colorado Hospital Patient safety Grant Role: Co-investigator Percent Effort: 5% Salary Offset: None Direct Costs: $24,850 Score: N/A Funded: Yes Funding Period: December 2007-2009

Unfunded Grant Activity

1. Title: Funding Agency: Stoneman Center for Quality Improvement in general Medicine and

Primary Care Role: Co-investigator Percent Effort: N/A Salary Offset: None Direct Costs: $20,000 Score: N/A Funded: No Funding Period: July 2000 – June 2001

Research In Progress (unfunded)

PUBLICATIONS Journal Articles

1. Misky GJ, Manheim JC, Zehnder N, Nguyen V, Swenson PF, Klem, Trujillo TC, Earnest MA. Health Care Disparities in the Acute Management of Venous Thromboembolism Based on Insurance Status in the U.S. J Thromb Thrombolysis (2011) 32:393–398.

2. Stacy ZA, Dobesh PP, Trujillo TC, Dager W, Ripley T, Olson KL. Key Articles and Guidelines in the Management of Peripheral Arterial Disease. Pharmacotherapy 2011;31(9):922.

3. Kiser TH, Mann AM, Trujillo TC, Hassell K. Evaluation of empiric versus nomogram-based direct thrombin inhibitor management in patients with suspected heparin-induced thrombocytopenia. Am. J. Hematol. 86:267–272, 2011

4. Dobesh PP, Trujillo TC. Anticoagulation in the Management of ST-Segment Elevation Myocardial Infarction. Journal of Pharmacy Practice 2010 23(4) 335-343. Published online 19 May 2010, 10.1177/0897190010366932 http://jpp.sagepub.com/cgi/content/abstract/0897190010366932v1

5. Dobesh PP, Trujillo TC. Anticoagulation in the Management of Non-ST-Segment Elevation Acute Coronary Syndrome. Journal of Pharmacy Practice 2010 23(4) 324-334. Published online 13 May 2010, 10.1177/0897190010366931. http://jpp.sagepub.com/cgi/content/abstract/0897190010366931v1

6. Trujillo TC. Emerging anticoagulants for venous thromboembolism Prevention. Am J Health-Syst

Pharm. 2010;67 (Suppl 6):S17-25. 7. Haines S, Dager W, Trujillo TC. Clinical and management challenges in preventing venous

thromboembolism in health systems: A case-based panel discussion. Am J Health-Syst Pharm. 2010; 67 (Suppl 6):S26-30

8. Goodwin SD, Kane-Gill S, Ng T, Melroy JT, Hess M, Tallian K, Trujillo TC, Vermeulen LC.

Rewards and Advancements for Clinical Pharmacy Practitioners: A Report from the ACCP Clinical Practice Affairs Committee, 2004-2005. Pharmacotherapy 2010;30(1):114.

9. Chow SL, Dorsch MP, Dunn, SP, Jackevicius, CA, Page, RL, Trujillo TC, Vardeny, O, Wiggins,

Pharm.D., Bleske, B. Key Articles Related to Complementary and Alternative Medicine in Cardiovascular Disease: Part 1. Pharmacotherapy 2010;30(1):109.

10. Dobesh PP, Wittkowsky AK, Stacy Z, Dager WE, Trujillo TC, Gulseth MP, Nutescu E, Vondracek T,. Key Articles and Guidelines in the Treatment of Venous Thromboembolism. Pharmacotherapy 2009;29(11):1385.

11. Dobesh PP, Wittkowsky AK, Stacy Z, Dager WE, Haines ST, Lopez LM, Nutescu E,

Phillips KW, , Trujillo TC, Vondracek T,. Key Articles and Guidelines in the Prevention of Venous Thromboembolism. Pharmacotherapy 2009;29(4):410–458.

12. Dobesh PP, Trujillo TC. Ranolazine: A New Option in the Management of Chronic Stable

Angina. Pharmacotherapy 2007;27(12):1659-1676.

13. Trujillo TC, Dobesh PP. Traditional Management of Chronic Stable Angina.

Pharmacotherapy 2007;27(12):1677-1692.

14. Trujillo, TC. Advances in the Management of Stable Angina. J Manag Care Pharm 2006;12(8):S10-S16.

15. Stacy ZA, Dobesh PP, Trujillo TC. Cardiovascular Risks of Cyclooxygenase-2 Inhibition.

Pharmacotherapy 2006;26(7):919-38.

16. Itkin YM, Trujillo TC. Acute Renal Failure Secondary to Administration of IVIG: Case Series and Review of the Literature. Pharmacotherapy 2005;25(6):886-892

17. Trujillo TC, Nolan PE. Antiarrhythmic Agents: Drug Interactions of Clinical

Significance. Drug Safety 2000;23(6):509-532.

18. Trujillo TC, Gandhi PJ. Bridging Low Molecular Weight Heparin and Warfarin in the Outpatient Setting. Drug Topics, November 2000.

19. Trujillo TC, Nolan PE. Unfractionated Heparin in Acute Coronary Syndromes: Has it's Time Come and Gone? Am J Health-Sys Pharm. 1998; 55:2402-9.

20. Trujillo TC. Postgraduate Pharmacy Training: Past Residents and Fellows Share Their Unique Experiences with CJHP. CJHP 1997;9(5): 13-16.

21. Trujillo TC, Kayser SR. Alcohol and Cardiovascular Disease. Progress in Cardiovascular Nursing. Spring 1995; 10(2):36-39.

22. Kayser SR, Trujillo TC. The Role of Magnesium in Cardiovascular Disease. Progress in

Cardiovascular Nursing. Fall 1994; 9(4): 37-40. Book Chapters/Workbooks

1. Nolan PE, Trujillo TC, Yeaman CM. Chapter 20: Quinidine. In: Murphy JE, 5th ed. Clinical Pharmacokinetics. Pocket Reference. Bethesda: American Society of Health-System Pharmacists. 2011

2. Nolan PE, Trujillo TC. Chapter 12: Lidocaine. In: Murphy JE, 5th ed. Clinical Pharmacokinetics. Pocket Reference. Bethesda: American Society of Health-System Pharmacists. 2011

3. Trujillo TC. Chapter 6. Thrombolytic Considerations When Used with Anticoagulants. In: Dager WE, Gulseth MP, Nutescu EA. Anticoagulation Therapy – A Point-Of-Care Guide. Bethesda: American Society of Health-System Pharmacists. 2011.

4. Trujillo TC. Chapter 7: Atrial Fibrillation. In: Katz MD, et al. Pharmacotherapy Principles and

Practice Study Guide – A Case-Based Care Plan Approach. The McGraw-Hill Companies, Inc. New York, NY 2011.

5. Trujillo TC. Chapter 15: Venous Thromboembolism. In: Crouch MA, 1st ed. Cardiovascular

Pharmacotherapy. A Point-of care Guide. Bethesda: American Society of Health-System Pharmacists. 2010.

6. Trujillo TC, Nolan PE. Ischemic Heart Disease. In: Applied Therapeutics: The Clinical

Use of Drugs, 9th ed. Lippincott, Williams and Wilkins, Baltimore, Md. 2008

7. Nolan PE, Trujillo TC. Chapter 12: Lidocaine. In: Murphy JE, 4th ed. Clinical Pharmacokinetics. Pocket Reference. Bethesda: American Society of Health-System Pharmacists. 2007

8. Goodwin D, Hess M, Kane-Gill S, Ng T, Tallian K, Trujillo T, Vermeulen L, West K, Kehoe W.

Business Practice Model for Clinical Pharmacy Services in the Inpatient Setting. In: Schumock G, Stubbings J. How to Develop a Business Plan for Pharmacy Services. Lenexa, KS: American College of Clinical Pharmacy, 2007:109-136.

9. Trujillo T. Chronic Stable Angina: Management and Prevention of Future Cardiovascular Events.

Pharmacotherapy Self-Assessment Program, 6th edition. Book 1, cardiology module III, released January 2007. http://ceportal.accp.com/index.pl?op=show;isa=Course;iid=708921.

10. Nolan PE, Trujillo TC. Chapter 2: Complications of Medications. In: Complications of

Percutaneous Coronary Interventions, 1st edition. Springer- Science + Business Media. New York, New York. 2005.

11. Trujillo TC, Nolan PE. Ischemic Heart Disease. In: Applied Therapeutics: The Clinical

Use of Drugs, 8th ed. Lippincott, Williams and Wilkins, Baltimore, Md. 2004 12. Nolan PE, Trujillo TC. Chapter 11: Lidocaine. In: Murphy JE, 3rd ed. Clinical Pharmacokinetics.

Pocket Reference. Bethesda: American Society of Health-System Pharmacists. 2004 13. Trujillo TC, Nolan PE. Ischemic Heart Disease. In: Applied Therapeutics: The Clinical

Use of Drugs, 7th ed. Lippincott, Williams and Wilkins, Baltimore, Md. 2001. 14. Nolan PE, Trujillo TC. Chapter 11: Lidocaine. In: Murphy JE, 2nd ed. Clinical Pharmacokinetics.

Pocket Reference. Bethesda: American Society of Health-System Pharmacists. 2001. 15. Kosegarten D, Vogenberg R, Pisano D. editors. Mastering Pharmacy Licensure and

Certification: A case based review. Contributing author for study guide. Provided sample cases with answers in the areas of IHD, arrhythmia's, and CHF. New York: McGraw-Hill, 2000.

16. Clinical Pharmacy and Therapeutics, Sixth edition. Contributing author in casebook

for Herfindal's and Gourley's Textbook of Therapeutics: Drug and Disease Management. Case #'s 24, 61, 74, and 81.

Abstracts – Poster Presentations 2011 Carlson T, Klem P, Trujilllo T, Babilonia K, Madrid K, Whitehill C, Woodhouse G,

Kemp-Jackson C, Nordenholz K, Misky G. Development and Implementation of a Clinical Care Pathway for Acute VTE Improves Clinical Outcomes and Reduces Cost. Presented at the 2011 Rocky Mountain Hospitalist Symposium. Denver, CO. October 6, 2011

2011 Hemstreet B,Vondracek S, Trujillo T, Namdar R, Ellis S, Thompson L. Incorporation

Of A Simulated Medication Reconciliation Exercise In A Second Year Pharmacy School Active

Learning Curriculum. Presented at the 2011 Rocky Mountain Hospitalist Symposium. Denver, CO. October 6, 2011

2011 Carlson T, Klem P, Trujilllo T, Babilonia K, Madrid K, Whitehill C, Woodhouse G,

Kemp-Jackson C, Nordenholz K, Misky G. Development and Implementation of Acute Deep Vein Thrombosis (DVT) Clinical Care Pathway Decreases Admissions and 30–day Emergency Department (ED) Returns. Presented at the 2011 Society of Academic Emergency Medicine. Boston, MA. June 2nd, 2011.

2010 Mann AL, Trujillo TC, Hassell KL, Kiser TH. Evaluation of a direct thrombin inhibitor

titration protocol in patients with heparin induced thrombocytopenia. Presented at the 2010 Annual Meeting of the American College of Clinical Pharmacy. Austin, TX October 17-20, 2010.

2010 Valzez C, Hoody D, Hemstreet B, Vondracek S, Trujillo T, Saseen J. Impact of

Student Directed Activities and personalized Formative feedback on Skills Development in a Large Class. Presented at 2010 Annual Meeting of the American Academy of Colleges of Pharmacy. Seattle, WA. July 10-13 2010.

2010 Nguyen V, Swenson PF, Zehnder N, Earnest MA, Mellis K, Klem P, TrujilloT,

Manheim J, Ledford S, Misky GJ. Not All Health Care is Equal: Difference in Acute Care of venous Thromboembolism Based on Insurance. Presented at the 2010 Annual Meeting of the Society of General Internal Medicine. Minneapolis, MN April 28- May 1, 2010.

2010 Nguyen V, Swenson PF, Zehnder N, Earnest MA, Mellis K, Klem P, TrujilloT,

Manheim J, Ledford S, Misky GJ. Not All Health Care is Equal: Difference in Acute Care of venous Thromboembolism Based on Insurance. Presented at the 2010 Annual Meeting of the Society of Hospital Medicine. Washington DC April 8-11, 2010.

2009 Trujillo TC, Page RL, Wiggins B, Vardeny O, and the Cardiology PRN Membership.

Getting To the Heart of the Cardiology Practice and Research Network: A Historical Evaluation and Reflection. Presented at the 2009 Annual Meeting of the American College of Clinical Pharmacy. Anaheim, CA October 20-23, 2009

2008 Rinka J, Trujillo TC. Impact of the Timing of Initial Partial Thromboplastin Time on

Duration to Achievement of Therapeutic Anticoagulation with Intravenous Unfractionated Heparin. Presented at the 2008 Spring Practice and Research Forum of the American College of Clinical Pharmacy. Phoenix, AZ. April 5-9. 2008

2007 Alvidrez A, Trujillo TC, Arena L. Implementation of Clinical Pharmacy Services in a

Cardiomyopathy Clinic. Presented at the 2007 Annual Meeting of the American College of Clinical Pharmacy. Denver CO. October 14-17, 2007.

2007 Shinkazh N, Phillips K, Trujillo TC. Assessment of the Impact of

Various Dosing Intervals on the Delivery of Effective Venous Thromboembolism Prophylaxis in Medically Ill Patients. Presented at the 2007 Annual Meeting of the American College of Clinical Pharmacy. Denver CO. October 14-17, 2007.

2007 Law C, Mannello J, Arnold L, Trujillo TC, Gail M Burniske. Evaluation of a Discharge Pharmacy Services Program. Presented at the 2007 Annual Meeting of the American College of Clinical Pharmacy. Denver CO. October 14-17, 2007.

2007 K. Phillips, T. Trujillo, M. Miscioscia. An Observational Evaluation of Inpatient Warfarin

Utilization and Management. Presented at The Anticoagulation Forum: Ninth National Conference on Anticoagulant Therapy. Chicago, IL. May 3-5, 2007.

2007 Taiwo E, Sobieraj J, Greenwald J, Phillips K, Trujillo T, Ansell J. Effect of Mandatory

Electronic Order Set on the Ordering of DVT Prophylaxis in Medical Patients: A Prospective and Retrospective Study. Presented at The Anticoagulation Forum: Ninth National Conference on Anticoagulant Therapy. Chicago, IL. May 3-5, 2007.

2007 Chang J, Roberts K, Trujillo T. Observational Assessment of the Effect of Propofol on the

Incidence of Adverse Cardiovascular Events as Compared to Benzodiazepines. Presented at the 2007 Spring Practice and Research Forum of the American College of Clinical Pharmacy. Memphis, TN. April 21-25 , 2007.

2006 M. Rivera, F. Forsa, K. Thomasset, I. Lat, T. Trujillo. Evaluation of Venous

Thromboembolism (VTE) Prophylaxis in Surgical Patients. Presented at the 2006 Annual Meeting of the American College of Clinical Pharmacy. St. Louis, MO. October 26-29, 2006.

2006 K. Phillips, T. Trujillo. An Evaluation of Anticoagulation Control in Heart Failure: A

descriptive assessment of the quality of anticoagulation control and the risks of adverse events in heart failure patients on warfarin. 2006 Spring Practice and Research Forum of the American College of Clinical Pharmacy. Monterey, CA. April 9-12, 2006

2005 K. Phillips, T. Trujillo. An Evaluation of Anticoagulation Control in Heart Failure: A

descriptive assessment of the quality of anticoagulation control and the risks of adverse events in heart failure patients on warfarin. Presented during cardiology prn session, 2005 Annual Meeting of the American College of Clinical Pharmacy. San Francisco, CA. Oct. 22-25, 2005

2005 Trujillo TC, J. Mannello. Improvements in Enoxaparin Prescribing Secondary to

Optimization of Computerized Physician Order Entry (CPOE) and Implementation of a Pharmacist Directed Dosing Protocol. Presented at The Anticoagulation Forum: Eighth National Conference on Anticoagulant Therapy. Orlando, FL. May 5-7, 2005.

2005 Burniske G, Burnett AE, Greenwald J, Trujillo TC. Post-discharge Follow-up Phone

Call by a Pharmacist and Impact on Patient Care. Presented at The 2005 Annual Meeting of the Society of Hospital Medicine. Chicago, IL. April 28-30, 2005.

2005 Trujillo TC. Improvements in Enoxaparin Prescribing Secondary to Optimization of Computerized Physician Order Entry (CPOE) and Implementation of a Pharmacist Directed Dosing Protocol. Presented at the 2005 Spring Practice and Research Forum of the American College of Clinical Pharmacy. Myrtle Beach, SC. April 10-13, 2005.

2004 Burniske G, Burnett AE, Trujillo TC, Greenwald J. Post-discharge Follow-up Phone Call

by a Pharmacist and Impact on Patient Care. Finalist, Best Poster Competition.

Presented at the 2004 Annual Meeting of the American College of Clinical Pharmacy. Dallas, TX. October 24-27, 2004.

2004 Gongleski CA, Trujillo TC, Levitsky AL. Assessment of the Accuracy of Renal Dosing

Recommendations Made by Pharmacists. Presented at the 2004 Annual Meeting of the American College of Clinical Pharmacy. Dallas, TX. October 24-27, 2004.

2004 Baribeault D, Trujillo TC, Levitsky A. Guideline Development for the Administration of

Darbopoetin Alfa for the Treatment of Chemotherapy Induced Anemia in a University Teaching Hospital. Presented at the 2004 American Society of Health-System Pharmacy Annual Meeting. Las Vegas, NV. June 21-24, 2004.

2004 Baribeault D, Trujillo TC, Levitsky A. Positive Effects of a Pharmacist’s Involvement in the

Management of Anemia With Darbopoetin alfa in an Academic Teaching Institute. Presented at the 2nd ACCP-ESCP International Congress on Clinical Pharmacy. Paris, France April 28-29, 2004

2003 Burniske G, Trujillo TC, Greenwald J. Telephone Follow-up after Discharge from a

Medicine Ward by a Pharmacist. Presented at the 2003 American Society of Health System Pharmacy Clinical Midyear Meeting. New Orleans, LA. December 7-11, 2003

2000 Desyatnik MV, Trujillo TC, Baaj A Industry Rotation Experience in the Setting of a

Pharmacy Practice Residency. Presented at the 2000 American Society of Health System Pharmacy Midyear Clinical Meeting. Las Vegas, NV. December 2-7, 2000.

2000 Desyatnik MV, Trujillo TC Clinical and Economic Impact of a Pharmacy Practice Resident:

A Cost-Benefit Analysis. Presented at the 2000 American College of Clinical Pharmacy Annual Meeting. Los Angeles, CA. November 5-8, 2000.

1999 Horowitz GL, Means JM, Jean-Noel A, Trujillo TC, et al. Accuracy and Clinical

Correlation of International Normalized Ratio Testing by three Point-of-Care Testing Devices versus Traditional Laboratory Testing. 2000 American College of Clinical Pharmacy Spring Practice and Research Forum. Monterrey, CA. April 1-5, 2000.

Newsletters

1. Dobesh PP, Oestreich JH, Trujillo TC. Optimizing Oral Antiplatelet Therapy in Acute Coronary

Syndrome – Practice Tips and frequently Asked Questions. ASHP Advantage Newsletter, May 2011. http://www.ashpadvantagemedia.com/optimize/nl-optimize-052011.pdf

. 2. Dobesh PP, Oestreich JH, Trujillo TC. Optimizing Oral Antiplatelet Therapy in Acute Coronary

Syndrome – Why Focus on Antiplatet Therapy? ASHP Advantage Newsletter, March 2011. http://www.ashpadvantagemedia.com/optimize/nl-optimize-032011.pdf

3. Trujillo TC, Haines S, Dager W. Practice Pearls in the Changing Face of Anticoagulant Therapy.

ASHP Advantage Newsletter, Winter 2010. http://www.ashpadvantage.com/vte/vte-winter-newsletter.pdf

4. Trujillo TC, Haines S, Dager W. Tips for Managing Anticoagulation in Health Systems and Update on Emerging Anticoagulants. ASHP Advantage Newsletter, Spring 2010. http://www.ashpadvantage.com/vte/vte-spring-newsletter.pdf

5. Trujillo TC. Network News Bytes: Dofetilide: A new antiarrhythmic agent for atrial

fibrillation. ASHP Specialists' Spectrum. Spring 2000;6(2): 3. 6. Trujillo TC. Network News Bytes: New Guidelines for the Management of Congestive

Heart Failure. ASHP Specialists' Spectrum. Spring 1999,5(2): 6. 7. Trujillo TC. Danaparoid: Potentially Useful Agent in the Treatment of Heparin Induced

thrombocytopenia. ASHP Specialists'Spectrum. Spring 1998;5(2): 3-11. PRESENTATIONS

Invited Presentations – National 2011 Contemporary Considerations in Anticoagulation Management – Update in Current

Anticoagulation Therapy. CE presentation at the 46th Annual American Society of Health System Pharmacists Midyear Clinical Meeting. December 8, 2011. New Orleans, LA.

2011 Moderator for AHA Session titled “Anticoagulation 2011: New Opportunities and

new Challenges”. Presented at the 2011 AHA Scientific Sessions, November 13th, 2011. Orlando, FL.

2011 Preventing Stroke in Atrial Fibrillation – Overview of New and Emerging

Antithrombotic Agents and Roles for Pharmacists. CE presentation to the Connecticut Society of Health System Pharmacists October 15, 2011. Groton, CT.

2011 Controversies in Antithrombotic Monitoring. Rocky Mountain Hospital Medicine

Symposium. Denver, CO. October 7, 2011. 2011 Optimizing Clinical and Cost outcomes in Acute Coronary Syndrome. Pharmacy

Learning Network CE Program. Houston, TX. July 23, 2011. 2011 Recent Advances with Cardiovascular Pharmacotherapy in the ICU: from ACLS to

Anticoagulation. CE presentation at the 2011 American Society of Health System Pharmacists Summer Meeting. June 15, 2011. Denver, CO.

2011 New Therapeutic Agents for Arrhythmias. Presented on June 3rd, 2011 at the 10th

Summer Conference in Intensive Care Medicine – Acute Cardiac Care for the Society of Critical Care Medicine, Banff, Canada.

2011 Platelet Function Testing. Presented on June 3rd, 2011 at the 10th Summer

Conference in Intensive Care Medicine – Acute Cardiac Care for the Society of Critical Care Medicine, Banff, Canada.

2011 Preventing Stroke in Atrial Fibrillation – Overview of New and Emerging Antithrombotic Agents and Roles for Pharmacists. CE Webinar through ASHP Advantage. Presented on May 17th, 2011 and June 22nd, 2011

2011 Preventing Stroke in Atrial Fibrillation – Overview of New and Emerging

Antithrombotic Agents and Roles for Pharmacists. CE presentation to the New York City Society of Health System Pharmacists April 16, 2011. New York, NY.

2010 Future Directions in Antiplatelet Therapy. CE presentation at the 45th Annual

American Society of Health System Pharmacists Midyear Clinical Meeting. December 8, 2010. Anaheim, CA

2010 Update on Oral Antiplatelet Therapy in Acute Coronary Syndrome. CE

presentation at the 45th Annual American Society of Health System Pharmacists Midyear Clinical Meeting. December 7, 2010. Anaheim, CA

2010 Optimizing Antithrombotic Dosing in Obese Patients. CE presentation at the

ACCP 2010 Annual Meeting. Austin, TX. October 19, 2010. 2010 Connecting Clinical Evidence and Pharmacology in Managing Acute Coronary

Syndrome. Pharmacy Learning Network CE Program. Washington DC. September 18, 2010.

2010 Improving Adherence to VTE Prophylaxis Guidelines and Measures:

Opportunities for Health-System Pharmacists to Make a Clinical and Economic Impact. Pharmacy Learning Network CE Program. Washington DC. September 18, 2010.

2009 New Agents and technologies for VTE Prophylaxis. CE presentation at the 44th

Annual American Society of Health System Pharmacists Midyear Clinical Meeting. December 8th, 2009. Las Vegas, NV.

2009 Cardiology Update: Recent Advances in Coronary Artery Disease and Atrial

Fibrillation. CE presentation at the Oregon Society of Health-System Pharmacists Annual Meeting. Gleneden Beach, OR. April 26, 2009.

2008 Guidelines for Anticoagulant and Antiplatelet Therapy in Patients with STEMI.

Presented as part of midday symposia titled “A Coordinated Approach to Ensuring Safe and Appropriate Anticoagulation and Antiplatelet Therapy in health Systems. CE presentation at the 2008 ASHP Midyear Clinical Meeting. Orlando, FL. December 9, 2008.

2008 Improving Outcomes of Anticoagulant Therapy in Patients with Non-ST-Elevation

Acute Coronary Syndrome: 2008 Update. CE presentation to the Michigan Society of Health System Pharmacists. Novi, MI. November 12, 2008.

2008 Optimization of the Management of Patients with CAD. Presented as part of pre-

meeting symposia entitled “Current Topics in Ambulatory Cardiology”. CE presentation at the ACCP 2008 Annual Meeting. Louisville, KY. October 18, 2008.

2008 Translating Knowledge to Clinical Practice in the Management of Acute Coronary Syndrome. Satellite Symposia at the ACCP 2008 Annual Meeting. Louisville, KY. October 18, 2008.

2008 Applying ACC / AHA Guidelines for Anticoagulant Agents in the Management of

Acute Coronary Syndrome. CE presentation at Minority Health Conference and ABHP Annual Meeting. Atlanta, GA. May 17, 2008.

2007 Evidence-based Strategies in the Prevention and Management of Venous

Thromboembolism: A Focus on Antithrombotic Therapy. CE presentation to the Arizona Pharmacy Alliance. Phoenix and Tucson, AZ. Nov. 29th and 30th, 2007.

2007 Evidence-based Strategies in the Prevention and Management of Venous

Thromboembolism: A Focus on Antithrombotic Therapy. CE presentation to the North Carolina Association of Pharmacy Meeting. Raleigh, NC. Oct. 29th, 2007.

2007 Duration of Anti-platelet Therapy Should be Continued Indefinitely for the

Prevention of In-stent Thrombosis (statement against). Presented as part of the Cardiology PRN Focus Session – Debates in Cardiovascular Pharamcotherapy. Presented at the 2007 Annual Meeting of the American College of Clinical Pharmacy. Denver CO. October 15th, 2007.

2007 Antithrombotic Therapy in Acute Coronary Syndrome (ACS) and Venous

Thromboembolism (VTE). Presentation at Satellite Symposia titled “managing Thromboembolic Disease: Application of Evolving Clinical Evidence To patient Cases. Presented at the 2007 Annual Meeting of the American College of Clinical Pharmacy. Denver CO. October 16th, 2007.

2007 Evidence-based Strategies for Improving Patient Outcome: Optimizing

Antithrombotic Management of Acute Coronary Syndromes. CE presentation to the South Carolina Society of Health System Pharmacists. Columbia SC. October 11th, 2007

2007 Evidence-based Strategies for Improving Patient Outcome: Optimizing

Antithrombotic Management of Acute Coronary Syndromes. CE presentation to the Illinois Society of Health System Pharmacists. Chicago, IL. September 13th, 2007

2007 Evidence-based Strategies for Improving Patient Outcome: Optimizing

Antithrombotic Management of Acute Coronary Syndromes. . CE presentation to the Texas Society of Health-System Pharmacists. San Antonio, TX. April 20th, 2007

2007 Evidence-based Strategies in the Prevention and Management of Venous

Thromboembolism: A Focus on Antithrombotic Therapy. CE presentation to the Oklahoma Society of Health-System Pharmacists. Oklahoma City, OK. April 13th, 2007

2006 A New Therapeutic Approach for Chronic Stable Angina: Results from Recent

Clinical Trials. CE Satellite Symposium Presentation at the 2006 ACCP Annual meeting. St Louis, MO. October 28th, 2006.

2006 Clopidogrel Dosing: How Much and When? CE Presentation at the 2006 American College of Clinical Pharmacy Spring Practice and research Forum. Monterey, CA. April 10th, 2006.

2006 Advances in the Management of Stable Angina. CE Presentation at the 18th Annual

meeting and Showcase of the Academy of Managed Care Pharmacy. Seattle, WA. April 5th, 2006.

Invited Presentations – Regional

2011 Recent Advances in Anticoagulant Therapy: Practical Considerations for the

Pharmacists. Presented at the Colorado Pharmacists Society’s 19th Annual Winter Continuing Education Seminar: January 11th, 2011. Avon, Colorado.

2010 Treatment of Acute Coronary Syndromes: Recent Guideline Updates and Advances

in Antithrombotic Therapy. Presented at the 2010 Annual Fall Meeting of the Colorado Pharmacists Society. October 15, 2010. Denver, CO.

2009 Performance Improvement Workshop: Improving Patient Outcomes in

Thromboembolic Disorders. Participated as 1 of 4 speaker and facilitators in 1 ½ day workshop in Houston, TX (9/11-12/09), Fort Lauderdale, FL (9/25/26/09) and Boston, MA (10/1-2/09).

2009 VTE in Special Populations: Bridging the Gap Between Current and Optimal

Pharmacy Practice Across the Continuum of Care. Pharmacy Learning Network CE Program. San Mateo, CA. May 9, 2009

2008 Optimizing Anticoagulation in Acute Coronary Syndromes – A Workshop for

Pharmacists. CE presentation to Chicago are pharmacists. Oak Brook, IL. October 4th, 2008

2007 Evidence-based Strategies in the Prevention and Management of Venous

Thromboembolism: A Focus on Antithrombotic Therapy. CE presentation to the Atlanta area pharmacists. Atlanta, GA. Nov. 13, 2007.

2007 Evidence-based Strategies in the Prevention and Management of Venous

Thromboembolism: A Focus on Antithrombotic Therapy. CE dinner to Charlotte pharmacists. Charlotte, NC. June 12th, 2007.

2007 Chronic Heart Failure for the Community Pharmacist: A Focus on Beta-blockade.

CE presentation for the Vermont Pharmacists Association. Mendon, VT. May 6th 2007.

2007 Evidence-based Strategies for Improving Patient Outcome: Optimizing

Antithrombotic Management of Acute Coronary Syndromes. CE dinner presentation to Philadelphia pharmacists. Philadelphia, PA. May 3rd, 2007.

2007 Advanced on the Management of Chronic Stable Angina: Focus on Ranolazine.

CE presentation to the Rhode Island Society of Health System Pharmacists. Providence, RI. March 27th, 2007

2006 Acute Decompensated Heart Failure: State of the Art. Presentation to Regional Pharmacists. Third Annual New England Critical Care Pharmacy Symposium. Boston, MA. March 17th, 2006.

2005 NSAIDS and Cardiovascular Disease: Are Patients at Risk?. CE presentation to

regional pharmacists. Professional development Day #4. Northeastern University, Boston, MA. November 20, 2005.

2005 Prevention of Secondary Stroke in Stroke and TIA Patients. CE presentation to

regional pharmacists. Plymouth, MA. November 15th, 2005. 2005 Acute Coronary Syndromes: Applying Current Treatment Guidelines in the ICU

Setting. Presentation to Regional Pharmacists, Second Annual New England Critical care Symposium. Boston, MA. April 15th, 2005.

2004 Recent Advances in Cardiovascular Medicine: What the Community Pharmacist

Needs to Know. CE presentation to regional pharmacists. Professional development Day #6. Northeastern University, Boston, MA. December 19, 2004.

2004 The Community Pharmacist’s Role in Reducing Cardiac Risk. CE presentation to

regional pharmacists. Professional development Day #4. Northeastern University, Boston, MA. November 21, 2004.

2004 Reducing Cardiac Risk: A focus on ACE Inhibitors. CE presentation to

Connecticut Society of Health-System Pharmacists. Storrs, CT. September 21st, 2004

2004 Reducing Cardiac Risk: A focus on ACE Inhibitors. CE presentation to Vermont

Society of Health-System Pharmacists. Montpelier, VT. September 13th, 2004 2004 Treatment of Hypertension: Translating New Information Into Patient Care. CE

Presentation to regional pharmacists. Portland, ME. May 27th, 2004.

Invited Presentations - Local

2011 Anticoagulation Update: Bridging Therapy Overview and Dabigatran

Etexilate. Neurosurgery Grand Rounds, University of Colorado Hospital. August 30, 2011

2011 Recent Advances in Anticoagulant Therapy: Will New Oral Agents Render Warfarin a Thing of the Past? General Internal Medicine Grand Rounds, University of Colorado Hospital. August 16, 2011

2010 Clinical Pearls in Anticoagulation Management – Special Populations and Heparin

Use. Pharmacy Grand Rounds, University of Colorado Hospital. June 16, 2010. Aurora, CO.

2009 New management Option in the Treatment of Atrial Fibrillation – Dronedarone.

Presentation for local pharmacists, nurses, and physicians. September 23rd and December 17th, 2009. Denver, CO.

2009 Optimization of Anti-thrombotic Therapy. Pharmacy Grand Rounds presentation for CE credit, University of Colorado Hospital. August 19th and 25th, 2009.

2009 Genetic Testing and Warfarin: Ready for Prime Time? CE presentation to local

pharmacists at “Advances in Pharmacy Practice 09” Symposium. Sponsored by University of Colorado Denver, School of Pharmacy and Colorado Pharmacists Society. Aurora, CO. February 21, 2009.

2007 Chronic Heart Failure for the Community Pharmacist: A Focus on Beta-blockade.

CE presentation to local pharmacists. Braintree MA, March 21st 2007; Westport, MA, May 31st 2007; Shrewsbury MA July 31st 2007; Lynnfield MA, September 18th 2007.

2007 Treatment Options for Veteran Patients Requiring Anti-platelet Therapy. CE

presentation to local pharmacists. Boston, MA. March 20th, 2007. 2006 Advances in the Management of Chronic Stable Angina. CE presentation to local

pharmacists. Boston, MA. December 16, 2006. 2006 Deep Venous Thrombosis: Current Trends Focusing on Advances in Therapeutics

and Prevention. CE presentation to local pharmacists. Boston, MA. November 28th, 2006.

2006 Secondary Prevention in Patients with Cardiovascular Diseases: Role of the

Pharmacist. CE presentation to local pharmacists. Lynnfield, MA. September 27th, 2006

2006 Deep Venous Thrombosis: Current Trends Focusing on Advances in Therapeutics

and Prevention. CE presentation to local pharmacists. Boston, MA. March 2nd, 2006.

2005 Thrombosis in Heart Failure: Is there a role for chronic anticoagulation?.

Educational lecture for medical staff, cardiomyopathy grand rounds, Boston Medical Center. Boston, MA. May 11th, 2005.

2004 Brain Attack: Update on the Prevention of Stroke. CE presentation to long term

care nurses and pharmacists. Plymouth, MA. May 17th, 2004. 2004 Brain Attack: Update on the Prevention of Stroke. CE presentation to long term

care pharmacists. North Grafton, MA. March 23rd , 2004

Contributed Presentations 2007 Effect of a Mandatory Electronic VTE Risk Assessment on the Ordering of VTE

Prophylaxis in medically Ill Patients. Presented as a platform presentation at the 2007 Annual Meeting of the American College of Clinical Pharmacy. Denver CO. October 16th, 2007.

1997 Evaluation of the Predictive Performance of a Multi-demographic Based Heparin Dosing Protocol in Acute Coronary Syndromes. Presentation of cardiovascular fellowship research project at Western States Conference. Monterey, California.

1996 Optimization of Heparin Therapy in Patients with Unstable Angina and Acute

Myocardial Infarction Using a Multiple Regression Derived Heparin Dosing Nomogram. Scientific Plenary Presentation: American College of Clinical Pharmacy Annual Meeting. Nashville, Tennessee. August 3-7, 1996.

1996 Optimization of Heparin Therapy in Patients with Unstable Angina and Acute

Myocardial Infarction Using a Multiple Regression Derived Heparin Dosing Nomogram. Presentation of interim results of cardiovascular fellowship project at Western States Conference. Monterey, California.

1995 The Relationship of Antithrombin III (AT III). Heparin Response, and Outcome

During Percutaneous Transluminal Coronary Angioplastv. Presentation of residency research project at Western States Conference. Monterey, California.

RESIDENTS SUPERVISED Boston Medical Center – Specialty Residency in Cardiology Joseph Rinka, Pharm.D. 2007-2008 Research Projects:

1) Assessment of the impact of various dosing intervals on the delivery of appropriate prophylaxis for venous thromboembolism in hospitalized medically ill patients

2) Impact of the timing of initial partial thromboplastin time on duration to achievement of therapeutic anticoagulation with intravenous unfractionated heparin.

Jessica Chang, Pharm.D. 2006-2007. Research Project: An observational assessment of the effect of propofol on the incidence of adverse cardiovascular events as compared to benzodiazepines Kate Phillips, Pharm.D. 2005-2006. Research Project: An evaluation of anticoagulation control in heart failure: A descriptive assessment of the quality of anticoagulation control and the risks of adverse events in heart failure patients on warfarin. Jennifer Falvey, Pharm.D. 2004-2005. Research Project: Assessment of the treatment of acute decompensated heart failure on medicine teams Walt Schroeder, Pharm.D. 2003-2004 Research Project: Treatment of cardiovascular disease in patients with diabetes and a vascular diagnosis Boston Medical Center – Pharmacy Practice Amy Partridge, Pharm.D. 2006-2007. Research Project: Effect of Loratadine on the Severity and Duration of Bone Pain Associated with Pegfilgrastim Administration.

Delila Katz, Pharm.D. 2006-2007. Research Project: Evaluation of compliance with a severe sepsis/septic shock algorithm in the critical care setting. . Laura Aykroyd, Pharm.D. 2006-2007. Research Project: Effect of Diabetic Ketoacidosis Algorithm on Incidence of Adverse Events in the Medical Intensive Care Unit. Marianne Miscioscia, Pharm.D. 2006-2007. Research Project: Use of Propofol and Infection Risk in the ESICU population Lindsay Huynh, Pharm.D. 2006-2007. Research Project: Impact of a Pharmacist on Home Care Visits Regarding Medication Management and Patient Satisfaction Kathy Pang, Pharm.D. 2005-2006. Research Project: Diluted tincture of opium versus phenobarbital for the treatment of neonatal abstinence syndrome: A retrospective review. Melvin Rivera, Pharm.D. 2005-2006. Research Project: An Evaluation of VTE prophylaxis among surgical patients. Sarah Lipski, Pharm.D. 2005-2006. Research Project: Optimization of continuous intravenous unfractionated heparin. Wes McMillian, Pharm.D. 2005-2006. Research Project: Is the incidence of delirium an independent risk factor for mortality in the SICU? Kim Holden, Pharm.D. 2005-2006. Research Project: Treatment of acute decompensated heart failure on medicine teams. Kate Phillips, Pharm.D. 2004-2005. Research Project: Description of real world experience with eplerenone: Focusing on the incidence of hyperkalemia in the presence or absence of CYP 3A4 inhibitors. Lauren Decloe, Pharm.D. 2004-2005. Research Project: The impact of a prospective pharmacy – based monitoring service on vancomycin utilization. Danielle Kebadjian, Pharm.D. 2004-2005. Research Project: Determination of patient characteristics that predict low random levels with high dose, extended interval aminoglycoside therapy. Keri Roberts, Pharm.D. 2004-2005. Research Project: Cardiovascular effects of propofol as a sedative in the cardiac care unit. Allison Burnett, Pharm.D. 2003-2004. Research Project: Post-discharge follow-up phone call by a pharmacist and impact on patient care. Julie Mannello, Pharm.D. 2003-2004. Research Project: A retrospective, cohort study of olanzapine for adjunct sedation in intensive care unit patients.

Mimi Thomas, Pharm.D. 2003-2004. Research Project: Effect of educational outreach and daily follow up by a pharmacist on nursing compliance to a continuous insulin infusion protocol in the surgical intensive care unit.

Melissa Danek, Pharm.D. 2003-2004. Research Project: An assessment of angiotensin receptor blocker dose equivalency. Christine Gongleski, Pharm.D. 2003-2004. Research Project: Effect of pharmacist interventions to promote adherence to sedation guidelines in the medical ICU on clinical outcomes. Crystal Tom, Pharm.D. 2002-2003. Research Project: Implementation of a continuous insulin infusion protocol in the intensive care unit. Maryann Hawes, Pharm.D. 2002-2003. Research Project: A pharmacist-run phone triage system to reduce hospital admissions from chemotherapy related adverse events. Yelena Itkin, Pharm.D. 2002-2003. Research Project: Comparison of the current aminoglycoside dosing protocol utilized in the BMC NICU with the former NEOFAX dosing protocol. Laurie Schmitt, Pharm.D. 2001-2002. Residency Project: Comparison of three methods to assess time in therapeutic range for warfarin therapy at an anticoagulation clinic. Dana Whitney, Pharm.D. 2001-2002. Research project: Gentamicin monitoring and dosing in hemodialysis patients. Beth Israel Deaconess Medical Center in conjunction with The Massachusetts College of Pharmacy and Health Sciences General Practice Residency Program – Pharmacy Practice Margarita Desyatnik, Pharm.D. 1999-2000. Residency Project: Clinical and economical impact of a pharmacy resident: A cost-benefit analysis. Sharon Cox. Pharm.D. 2000-2001. Residency Project: Evaluation of the BIDMC adult inpatient diabetes treatment form.